New imaging test for colorectal, gastric, or pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study tests a new imaging agent that may help see certain cancers (colorectal, gastric, or pancreatic) more clearly on PET scans. It may help doctors better understand your tumor and guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You either have a suspected or confirmed colorectal, gastric, or pancreatic cancer, or you are a healthy volunteer.
- You are in generally good health.
- You can lie still for a PET/MR or PET/CT scan and are not very anxious in enclosed spaces.
- You are not pregnant or breastfeeding, and if you can become pregnant, you agree to use birth control during the study.
- You do not have a known allergy to the study substance, and your fasting blood sugar is not too high (≤11.0 mmol/L).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new PET/CT scan using a special tracer to detect cancer that has spread to the lining of the abdomen (peritoneal carcinomatosis) in people with colorectal, stomach, ovarian, or pancreatic cancer. It aims to see if this scan is better at finding the spread than standard imaging.
This trial tests a new PET imaging agent that targets a protein called FAP, which appears in many solid tumors. The goal is to see if this scan can better find and measure cancer in the body.
This trial uses a special imaging test (PET scan) to find digestive system cancers. It uses molecules that attach to cancer cells so they light up on the scan, which may help doctors see tumors more clearly.
This study tests a new PET scan tracer that targets a protein called Nectin-4, which is found on some cancer cells. It aims to improve how doctors detect and monitor cancers like bladder, breast, and lung cancer. If you have one of these cancers, this scan might help your doctor see your cancer more clearly.
This study tests a new imaging method (PET scan) that uses a special tracer to find prostate cancer cells, whether it's the first diagnosis or a recurrence after treatment. The goal is to see how well this imaging works for locating cancer in the body.
This study tests a new kind of PET scan that might better detect kidney cancer. It involves an injection of a special imaging agent and a scan to see if the cancer shows up clearly.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.